• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

Methyl 3-bromo-4-hydroxy-5-methoxybenzoate (CAS No. 108249-43-0): A Comprehensive Overview

Methyl 3-bromo-4-hydroxy-5-methoxybenzoate, identified by its CAS number 108249-43-0, is a significant compound in the realm of chemical and pharmaceutical research. This compound, featuring a benzoate core with bromine, hydroxyl, and methoxy substituents, has garnered attention due to its versatile applications in synthetic chemistry and potential biological activities. The unique structural attributes of Methyl 3-bromo-4-hydroxy-5-methoxybenzoate make it a valuable intermediate in the development of various pharmacological agents.

The benzoate moiety is a well-known pharmacophore in medicinal chemistry, contributing to the solubility and bioavailability of many drugs. The presence of bromine and hydroxyl groups introduces additional reactivity, enabling diverse functionalization pathways. These features are particularly useful in the synthesis of more complex molecules, such as inhibitors and agonists targeting specific biological pathways. Recent advancements in drug discovery have highlighted the importance of such intermediates in developing novel therapeutic agents.

In recent years, researchers have been exploring the potential of Methyl 3-bromo-4-hydroxy-5-methoxybenzoate in the synthesis of bioactive compounds. For instance, studies have demonstrated its utility in creating derivatives with antimicrobial and anti-inflammatory properties. The bromine substituent, in particular, has been shown to enhance binding affinity to certain protein targets, making it an attractive scaffold for drug design. This has led to several innovative approaches in medicinal chemistry, where Methyl 3-bromo-4-hydroxy-5-methoxybenzoate serves as a key building block.

The hydroxyl group in the molecule also plays a crucial role in its reactivity and biological activity. Hydroxylated benzoates are known to exhibit various pharmacological effects, including antioxidant and anti-proliferative properties. The methoxy group further modulates the electronic properties of the molecule, influencing its interactions with biological targets. These structural features collectively contribute to the compound's potential as a precursor for developing new drugs.

One of the most compelling aspects of Methyl 3-bromo-4-hydroxy-5-methoxybenzoate is its versatility in synthetic chemistry. It can be easily modified through various chemical reactions, such as nucleophilic aromatic substitution and etherification, allowing researchers to tailor its properties for specific applications. This flexibility has been exploited in several recent studies aimed at developing novel therapeutic agents. For example, researchers have used this compound to synthesize derivatives with enhanced efficacy against certain diseases.

The pharmaceutical industry has also shown interest in Methyl 3-bromo-4-hydroxy-5-methoxybenzoate due to its potential as a lead compound for drug development. Its structural framework aligns well with several drug targets, making it a promising candidate for further investigation. Preclinical studies have begun to explore its pharmacokinetic and pharmacodynamic properties, providing insights into its potential therapeutic applications. These studies are crucial for understanding how the compound behaves within biological systems and identifying its most promising uses.

In conclusion, Methyl 3-bromo-4-hydroxy-5-methoxybenzoate (CAS No. 108249-43-0) is a multifaceted compound with significant potential in chemical synthesis and pharmaceutical research. Its unique structural features make it an invaluable intermediate for developing novel bioactive molecules. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the discovery and development of next-generation therapeutics.

• 65841-10-3(methyl 3-bromo-4,5-dihydroxybenzoate)
• 6324-52-3(3-Bromo-4-hydroxy-5-methoxybenzoic Acid)
• 88108-14-9(Benzoic acid, 4-[(4-bromobenzoyl)oxy]-3-methoxy-, 4-methylphenyl ester)
• 432020-70-7(2-Bromo-4-formyl-6-methoxyphenyl benzoate)
• 431935-02-3(2-Bromo-6-ethoxy-4-formylphenyl benzoate)
• 671790-48-0(3-Bromo-4-Ethoxy-5-Methoxybenzoic Acid)
• 880277-76-9(Benzoic acid, 4-[(4-bromophenyl)methoxy]-3-methoxy-, methyl ester)
• 443908-04-1(4-Formyl-2-methoxyphenyl 4-bromobenzoate)
• 176240-84-9(Methyl 4-(benzyloxy)-3-bromobenzoate)
• 50772-79-7(methyl 3-bromo-4,5-dimethoxybenzoate)